Anisa Adyalina (2015) Studi Penggunaan Antidislipidemia Pada Pasien Penyakit Jantung Koroner (Penelitian Di Instalasi Rawat Jalan Jantung Dan Pembuluh Darah Rsud Dr. Soetomo Surabaya). Skripsi thesis, UNIVERSITAS AIRLANGGA.

	Text (HALAMAN JUDUL) 1. HALAMAN JUDUL.pdf Download (309kB)
	Text (ABSTRACT) 2. ABSTRACT.pdf Download (161kB)
	Text (BAB 1) 3. BAB I PENDAHULUAN.pdf Download (225kB)
	Text (BAB 2) 4. BAB II TINJAUAN PUSTAKA.pdf Restricted to Registered users only until 22 May 2023. Download (885kB) | Request a copy
	Text (BAB 3) 5. BAB III KERANGKA KONSEPTUAL DAN KERANGKA OPERASIONAL.pdf Restricted to Registered users only until 22 May 2023. Download (206kB) | Request a copy
	Text (BAB 4) 6. BAB IV METODE PENELITIAN.pdf Restricted to Registered users only until 21 May 2023. Download (246kB) | Request a copy
	Text (BAB 5) 7. BAB V HASIL PENELITIAN.pdf Restricted to Registered users only until 21 May 2023. Download (241kB) | Request a copy
	Text (BAB 6) 8. BAB VI PEMBAHASAN.pdf Restricted to Registered users only until 21 May 2023. Download (246kB) | Request a copy
	Text (BAB 7) 9. BAB VII KESIMPULAN DAN SARAN.pdf Restricted to Registered users only until 21 May 2023. Download (196kB) | Request a copy
	Text (LAMPIRAN) 11. LAMPIRAN.pdf Restricted to Registered users only until 21 May 2023. Download (415kB) | Request a copy

Abstract

Background. Coronary Heart Disease (CHD) is the leading cause of death in industrialized countries in the world. According to the World Heart Organization (WHO), 60% of all causes of death is Coronary Heart Disease. In Indonesia, Coronary Heart Diasease is also likely to increase as a cause of death.Antidislipidemic can be used to reduce the size of the plaque that can lead to a decrease in the incidence of acute coronary disease.Objective. To analyze the pattern of antidislipidemic utilization in the coronary heart disease patients.Method.The Observational studies and the type of data collection were done by cross-sectional method in which the patient's medical record data recorded from March to June 2014. Method of sampling was done by Purposive Non Random Sampling, with number of sample was 71 patients.Result and Discussion. In this study, there were 88,3% patients used simvastatin, 0,5% patients used atorvastatin and 3,3% patients used fenofibrat. Appropriate use of antidislipidemic occured in 88,7% patients. There were 36,7% patients experienced potential interactions of antidislipidemic drugs used and 11,2% patients experienced unappropriate use of antidislipidemic. Conclusion. Results of this study indicate that the use of antidislipidemic in CHD patients is appropriate but there are still some problems related potential drug interactions and unappropriate use of antidislipidemic

Actions (login required)

View Item